Tyr53
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr53  -  Vimentin (human)

Site Information
PstsrsLyAssPGGV   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448930
Available spectra:  1 CST
Associated spectra:  2 CST

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1132 , 1133 , 1134 , 1135 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1167 , 1168 , 1169 , 1170 , 1171 , 1172 , 1173 , 1174 , 1175 , 1176 , 1177 , 1178 , 1179 , 1180 , 1181 , 1182 , 1183 , 1184 , 1185 , 1186 , 1187 , 1188 , 1189 , 1190 , 1191 , 1192 , 1193 , 1194 , 1195 , 1196 , 1197 , 1198 , 1199 , 1200 , 1201 , 1202 , 1203 , 1204 , 1205 , 1206 , 1207 , 1208 , 1209 , 1210 , 1211 , 1212 , 1213 , 1214 , 1215 , 1216 , 1217 , 1218 , 1219 , 1220 , 1221 , 1222 , 1223 , 1224 , 1225 , 1226 , 1227 , 1228 , 1229 , 1230 , 1231 , 1232 , 1233 , 1234 , 1235 , 1236 , 1237 , 1238 , 1239 , 1240 , 1241 , 1242 , 1243 , 1244 , 1245 , 1246 , 1247 , 1248 , 1249 , 1250 , 1251 , 1252 , 1253 , 1254 , 1255 , 1256 , 1257 , 1258 , 1259 , 1260 , 1261 , 1262 , 1263 , 1264 , 1265 , 1266 , 1267 , 1268 , 1269 , 1270 , 1271 , 1272 , 1273 , 1274 , 1275 , 1276 , 1277 , 1278 , 1279 , 1280 , 1281 , 1282 , 1283 , 1284 , 1285 , 1286 , 1287 , 1288 , 1289 , 1290 , 1291 , 1292 , 1293 , 1294 , 1295 , 1296 , 1297 , 1298 , 1299 , 1300 , 1301 , 1302 , 1303 , 1304 , 1305 , 1306 , 1307 , 1308 , 1309 , 1310 , 1311 , 1312 , 1313 , 1314 , 1315 , 1316 , 1317 , 1318 , 1319 , 1320 , 1321 , 1322 , 1323 , 1324 , 1325 , 1326 , 1327 , 1328 , 1329 , 1330 , 1331 , 1332 , 1333 , 1334 , 1335 , 1336 , 1337 , 1338 , 1339 , 1340 , 1341 , 1342 , 1343 , 1344 , 1345 , 1346 , 1347 , 1348 , 1349 , 1350 , 1351 , 1352 , 1353 , 1354 , 1355 , 1356 , 1357 , 1358 , 1359 , 1360 , 1361 , 1362 , 1363 , 1364 , 1365 , 1366 , 1367 , 1368 , 1369 , 1370 , 1371 , 1372 , 1373 , 1374 , 1375 , 1376 , 1377 , 1378 , 1379 , 1380 , 1381 , 1382 , 1383 , 1384 , 1385 , 1386 , 1387 , 1388 , 1389 , 1390 , 1391 , 1392 , 1393 , 1394 , 1395 , 1396 , 1397 , 1398 , 1399 , 1400 , 1401 , 1402 , 1403 , 1404 , 1405 , 1406 , 1407 , 1408 , 1409 , 1410 , 1411 , 1412 , 1413 , 1414 , 1415 , 1416 , 1417 , 1418 , 1419 , 1420 , 1421 , 1422 , 1423 , 1424 , 1425 , 1426 , 1427 , 1428 , 1429 , 1430 , 1431 , 1432 , 1433 , 1434 , 1435 , 1436 , 1437 , 1438 , 1439 , 1440 , 1441 , 1442 , 1443 , 1444 , 1445 , 1446 , 1447 , 1448 , 1449 , 1450 , 1451 , 1452 , 1453 )
Disease tissue studied:
atrial fibrillation ( 672 , 686 , 687 , 701 , 702 ) , adenoid cystic carcinoma ( 545 , 547 ) , bladder cancer ( 307 , 308 , 936 , 988 , 1043 ) , bone cancer ( 18 , 754 , 755 , 756 , 791 , 792 , 793 , 794 , 795 , 1399 ) , Ewing's sarcoma ( 18 , 792 , 793 ) , osteosarcoma ( 754 , 755 , 756 , 791 , 794 , 795 , 1399 ) , brain cancer ( 18 , 81 , 82 , 85 , 283 , 284 , 285 , 286 , 287 , 329 , 537 , 594 , 827 , 951 , 1034 , 1035 , 1038 , 1081 , 1082 , 1190 , 1191 , 1208 , 1220 , 1233 , 1239 , 1240 , 1260 , 1264 , 1268 , 1269 , 1270 , 1296 , 1303 , 1319 , 1363 , 1388 ) , astrocytoma ( 81 , 82 , 85 , 537 , 594 , 1035 , 1264 , 1388 ) , glioblastoma ( 283 , 284 , 285 , 286 , 287 , 329 , 951 , 1034 , 1081 , 1082 , 1190 , 1191 , 1208 , 1233 , 1240 , 1268 , 1269 , 1270 , 1296 , 1303 , 1319 , 1363 ) , glioblastoma multiforme ( 827 , 1034 , 1081 , 1082 , 1208 , 1233 , 1269 , 1296 , 1303 ) , glioma ( 283 , 284 , 285 , 286 , 287 , 329 , 827 , 951 , 1034 , 1038 , 1081 , 1082 , 1190 , 1191 , 1208 , 1233 , 1240 , 1268 , 1269 , 1270 , 1296 , 1303 , 1319 , 1363 ) , Schwannoma ( 18 ) , breast cancer ( 110 , 111 , 143 , 146 , 147 , 178 , 181 , 302 , 305 , 306 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 667 , 668 , 669 , 670 , 671 , 677 , 678 , 689 , 690 , 732 , 737 , 738 , 800 , 803 , 828 , 958 , 959 , 960 , 974 , 975 , 989 , 990 , 991 , 992 , 993 , 1006 , 1045 , 1267 , 1290 , 1356 , 1357 , 1362 , 1414 , 1415 ) , breast adenocarcinoma ( 1362 ) , breast ductal carcinoma ( 1267 , 1290 ) , HER2 positive breast cancer ( 1 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, surrounding tissue ( 143 , 146 , 178 , 181 , 302 , 305 , 306 ) , breast cancer, triple negative ( 1 , 110 , 960 , 1290 ) , colorectal cancer ( 18 , 128 , 130 , 132 , 149 , 171 , 187 , 188 , 475 , 501 , 502 , 503 , 504 , 644 , 749 , 750 , 1093 , 1336 ) , colorectal carcinoma ( 18 , 749 , 750 , 1336 ) , colorectal cancer, surrounding tissue ( 129 , 131 , 133 , 186 , 190 , 474 , 499 , 645 , 646 , 647 , 648 , 649 ) , esophageal cancer ( 373 , 374 , 387 , 388 , 389 , 391 , 392 , 394 , 397 , 398 , 403 , 404 , 408 , 409 , 412 , 413 , 417 , 418 , 419 , 423 , 424 , 427 , 428 , 430 , 432 , 435 , 438 , 440 , 441 , 442 , 445 , 446 , 447 , 449 , 450 , 451 , 453 , 461 , 464 , 465 ) , esophageal cancer, surrounding tissue ( 390 , 393 , 395 , 396 , 399 , 400 , 401 , 402 , 405 , 406 , 407 , 410 , 411 , 414 , 415 , 416 , 420 , 421 , 422 , 425 , 426 , 429 , 431 , 433 , 434 , 436 , 437 , 439 , 443 , 444 , 448 , 456 , 458 , 459 , 460 , 462 , 463 , 467 , 468 ) , liposarcoma ( 18 ) , gastric cancer ( 292 , 295 , 296 , 555 , 556 , 558 , 560 , 562 , 564 , 565 , 568 , 570 , 571 , 576 , 577 , 579 , 583 , 585 , 586 , 588 , 589 , 680 , 682 , 683 , 699 , 703 , 709 , 710 , 715 , 716 , 720 , 722 , 723 , 976 ) , gastric carcinoma ( 555 , 556 , 558 , 560 , 562 , 564 , 565 , 568 , 570 , 571 , 680 , 682 , 683 , 703 , 709 , 710 , 716 ) , gastric carcinoma, surrounding tissue ( 293 , 294 , 297 , 554 , 557 , 559 , 561 , 563 , 566 , 567 , 569 , 578 , 580 , 584 , 587 , 590 , 679 , 681 , 696 , 697 , 698 , 721 , 724 ) , kidney cancer ( 310 , 323 , 328 , 761 , 762 , 934 ) , kidney cancer, surrounding tissue ( 312 ) , laryngeal cancer ( 653 , 807 , 814 ) , leukemia ( 34 , 35 , 36 , 37 , 38 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 163 , 164 , 172 , 215 , 220 , 222 , 224 , 225 , 232 , 233 , 244 , 245 , 247 , 248 , 249 , 250 , 251 , 252 , 255 , 256 , 257 , 264 , 265 , 266 , 276 , 277 , 278 , 281 , 282 , 289 , 300 , 303 , 304 , 318 , 365 , 366 , 367 , 368 , 381 , 509 , 510 , 511 , 516 , 517 , 652 , 663 , 664 , 665 , 666 , 706 , 730 , 731 , 783 , 784 , 785 , 789 , 790 , 796 , 797 , 799 , 809 , 810 , 811 , 812 , 813 , 839 , 840 , 841 , 846 , 851 , 852 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 869 , 870 , 872 , 924 , 954 , 955 , 956 , 957 , 977 , 978 , 979 , 985 , 986 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1008 , 1009 , 1010 , 1011 , 1023 , 1024 , 1025 , 1026 , 1027 , 1039 , 1040 , 1041 , 1042 , 1048 , 1061 , 1062 , 1063 , 1064 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1083 , 1089 , 1090 , 1091 , 1092 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1107 , 1108 , 1110 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1128 , 1130 , 1131 , 1132 , 1133 , 1134 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1169 , 1170 , 1171 , 1172 , 1173 , 1174 , 1175 , 1176 , 1177 , 1178 , 1179 , 1180 , 1181 , 1182 , 1183 , 1184 , 1185 , 1186 , 1187 , 1196 , 1201 , 1202 , 1203 , 1204 , 1224 , 1228 , 1229 , 1230 , 1231 , 1232 , 1242 , 1254 , 1255 , 1256 , 1257 , 1258 , 1259 , 1271 , 1272 , 1273 , 1274 , 1275 , 1276 , 1298 , 1302 , 1305 , 1306 , 1307 , 1315 , 1316 , 1317 , 1321 , 1327 , 1328 , 1331 , 1332 , 1334 , 1344 , 1345 , 1358 , 1364 , 1365 , 1366 , 1371 , 1372 , 1373 , 1374 , 1375 , 1386 , 1387 , 1390 , 1394 , 1395 , 1403 , 1405 , 1406 , 1407 , 1417 , 1421 , 1422 , 1432 , 1433 , 1438 , 1439 , 1440 , 1441 , 1448 ) , acute lymphocytic leukemia ( 127 , 1008 , 1009 , 1010 , 1011 , 1023 , 1024 , 1092 , 1104 , 1137 , 1138 , 1139 , 1140 , 1182 , 1254 , 1255 , 1256 , 1257 , 1364 , 1365 , 1366 , 1386 , 1387 , 1390 , 1407 , 1417 ) , acute myelogenous leukemia ( 127 , 809 , 810 , 811 , 812 , 813 , 846 , 851 , 852 , 858 , 859 , 860 , 861 , 862 , 924 , 977 , 978 , 979 , 985 , 986 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1025 , 1026 , 1027 , 1048 , 1069 , 1070 , 1071 , 1072 , 1091 , 1099 , 1100 , 1101 , 1102 , 1103 , 1107 , 1108 , 1110 , 1141 , 1142 , 1143 , 1144 , 1157 , 1158 , 1159 , 1160 , 1177 , 1178 , 1179 , 1180 , 1181 , 1183 , 1184 , 1201 , 1202 , 1203 , 1204 , 1224 , 1228 , 1229 , 1230 , 1231 , 1232 , 1258 , 1259 , 1302 , 1305 , 1306 , 1307 , 1315 , 1316 , 1317 , 1327 , 1328 , 1331 , 1332 , 1334 , 1344 , 1345 , 1358 , 1371 , 1372 , 1373 , 1374 , 1375 , 1405 , 1406 , 1421 , 1422 ) , chronic lymphocytic leukemia ( 1242 , 1298 , 1403 , 1432 , 1433 ) , chronic myelogenous leukemia ( 34 , 35 , 36 , 37 , 38 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 163 , 164 , 172 , 215 , 220 , 222 , 224 , 225 , 232 , 233 , 244 , 245 , 247 , 248 , 249 , 250 , 251 , 252 , 255 , 256 , 257 , 264 , 265 , 266 , 276 , 277 , 278 , 281 , 282 , 289 , 300 , 303 , 304 , 318 , 365 , 366 , 367 , 368 , 381 , 509 , 510 , 511 , 516 , 517 , 652 , 663 , 664 , 665 , 666 , 706 , 730 , 731 , 789 , 790 , 796 , 797 , 799 , 839 , 840 , 841 , 863 , 864 , 865 , 866 , 867 , 869 , 870 , 872 , 954 , 955 , 956 , 957 , 1039 , 1040 , 1041 , 1042 , 1061 , 1062 , 1063 , 1064 , 1067 , 1068 , 1089 , 1090 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1128 , 1130 , 1131 , 1132 , 1133 , 1134 , 1136 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1169 , 1170 , 1171 , 1172 , 1173 , 1174 , 1175 , 1176 , 1185 , 1186 , 1187 , 1271 , 1272 , 1273 , 1274 , 1275 , 1276 , 1321 , 1394 , 1395 , 1438 , 1439 , 1440 , 1441 , 1448 ) , liver cancer ( 125 , 194 , 195 , 196 , 197 , 198 , 199 , 311 , 322 , 332 , 334 , 335 , 341 , 342 , 343 , 347 , 350 , 353 , 354 , 357 , 358 , 360 , 363 , 472 , 473 , 477 , 478 , 479 , 480 , 481 , 483 , 485 , 487 , 488 , 489 , 490 , 497 , 498 , 500 , 524 , 538 , 539 , 540 , 619 , 626 , 628 , 631 , 676 ) , liver adenocarcinoma ( 473 ) , cholangiocellular carcinoma ( 125 , 335 , 342 , 477 , 481 , 487 , 498 , 500 ) , cholangiocellular carcinoma, surrounding tissue ( 340 , 352 , 486 , 627 , 633 , 726 , 729 ) , hepatocellular carcinoma ( 332 , 334 , 341 , 343 , 347 , 350 , 353 , 354 , 357 , 360 , 363 , 478 , 479 , 483 , 488 , 490 , 497 , 619 , 626 , 628 , 631 , 676 ) , hepatocellular carcinoma, surrounding tissue ( 333 , 345 , 346 , 348 , 349 , 355 , 359 , 361 , 484 , 495 , 496 , 624 , 629 , 632 , 727 , 728 ) , liver cancer, surrounding tissue ( 309 , 356 , 482 ) , lung cancer ( 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 24 , 33 , 80 , 83 , 84 , 90 , 91 , 92 , 93 , 95 , 145 , 201 , 216 , 217 , 219 , 221 , 223 , 230 , 231 , 267 , 268 , 271 , 272 , 273 , 275 , 369 , 372 , 375 , 376 , 377 , 378 , 491 , 505 , 506 , 507 , 508 , 512 , 513 , 543 , 574 , 581 , 591 , 592 , 605 , 691 , 692 , 693 , 694 , 695 , 704 , 705 , 707 , 708 , 741 , 742 , 743 , 744 , 745 , 802 , 805 , 806 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 913 , 914 , 915 , 916 , 917 , 920 , 921 , 922 , 927 , 928 , 929 , 930 , 935 , 994 , 1003 , 1004 , 1005 , 1007 , 1017 , 1018 , 1019 , 1020 , 1021 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1065 , 1066 , 1094 , 1096 , 1098 , 1113 , 1122 , 1124 , 1126 , 1129 , 1189 , 1200 , 1205 , 1206 , 1209 , 1210 , 1211 , 1213 , 1214 , 1215 , 1216 , 1221 , 1222 , 1223 , 1234 , 1235 , 1236 , 1237 , 1238 , 1243 , 1244 , 1245 , 1246 , 1247 , 1248 , 1249 , 1250 , 1251 , 1252 , 1253 , 1261 , 1262 , 1265 , 1266 , 1285 , 1287 , 1288 , 1289 , 1294 , 1304 , 1308 , 1309 , 1310 , 1318 , 1320 , 1335 , 1337 , 1338 , 1342 , 1346 , 1347 , 1348 , 1349 , 1350 , 1352 , 1367 , 1369 , 1370 , 1378 , 1383 , 1385 , 1413 , 1427 , 1428 , 1429 , 1431 ) , non-small cell lung cancer ( 5 , 6 , 7 , 8 , 10 , 11 , 12 , 14 , 16 , 17 , 24 , 33 , 80 , 83 , 84 , 90 , 91 , 92 , 93 , 95 , 201 , 230 , 267 , 268 , 271 , 272 , 273 , 275 , 377 , 491 , 505 , 506 , 507 , 543 , 574 , 581 , 591 , 605 , 691 , 692 , 693 , 694 , 695 , 704 , 705 , 707 , 708 , 741 , 742 , 743 , 744 , 745 , 802 , 805 , 806 , 829 , 830 , 831 , 835 , 836 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 904 , 913 , 914 , 915 , 916 , 917 , 927 , 928 , 929 , 930 , 994 , 1003 , 1004 , 1005 , 1007 , 1017 , 1018 , 1019 , 1020 , 1021 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1065 , 1066 , 1094 , 1096 , 1098 , 1113 , 1122 , 1124 , 1126 , 1129 , 1189 , 1200 , 1205 , 1206 , 1209 , 1210 , 1211 , 1215 , 1216 , 1221 , 1222 , 1223 , 1238 , 1253 , 1261 , 1262 , 1266 , 1294 , 1308 , 1309 , 1310 , 1318 , 1320 , 1335 , 1337 , 1338 , 1346 , 1347 , 1348 , 1349 , 1350 , 1352 , 1367 , 1369 , 1370 , 1378 , 1383 , 1385 , 1413 , 1427 , 1428 , 1429 , 1431 ) , non-small cell lung cancer, surrounding tissue ( 228 , 229 , 324 , 575 , 582 , 596 ) , non-small cell lung adenocarcinoma ( 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 24 , 33 , 80 , 83 , 84 , 90 , 91 , 92 , 93 , 95 , 201 , 267 , 268 , 271 , 272 , 273 , 275 , 505 , 506 , 507 , 543 , 591 , 835 , 836 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 94 , 269 , 270 , 274 ) , non-small cell large cell lung carcinoma ( 7 , 10 , 935 ) , non-small cell squamous cell lung carcinoma ( 9 , 17 , 24 , 369 , 372 , 375 , 376 , 378 , 508 , 512 , 513 , 592 , 1262 , 1335 ) , small-cell lung cancer ( 1265 ) , lung cancer, surrounding tissue ( 109 , 144 , 150 , 182 , 183 , 185 , 189 , 218 , 542 ) , lymphoma ( 99 , 202 , 712 , 713 , 714 , 787 , 969 , 970 , 971 , 972 , 1084 , 1085 , 1086 , 1087 , 1197 , 1212 , 1217 , 1218 , 1219 , 1241 , 1291 , 1292 , 1299 , 1353 , 1359 , 1360 , 1361 , 1391 , 1400 , 1404 , 1411 , 1412 , 1416 ) , anaplastic large cell lymphoma ( 1197 , 1241 , 1291 , 1292 , 1299 , 1359 , 1360 , 1361 , 1391 , 1400 , 1404 , 1416 ) , B cell lymphoma ( 99 , 1212 , 1217 , 1218 , 1219 , 1411 , 1412 ) , Hodgkin's lymphoma ( 202 , 787 , 969 , 970 , 971 , 972 , 1084 , 1085 , 1086 , 1087 ) , non-Hodgkin's lymphoma ( 99 ) , mantle cell lymphoma ( 99 ) , T cell lymphoma ( 1353 ) , myeloproliferative disorder ( 1109 , 1343 ) , neuroblastoma ( 2 , 952 , 953 , 961 , 965 , 966 , 980 , 981 , 1036 , 1037 , 1220 , 1239 , 1260 , 1263 ) , ovarian cancer ( 112 , 134 , 135 , 136 , 137 , 138 , 151 , 152 , 153 , 154 , 155 , 156 , 161 , 211 , 213 , 214 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 763 , 764 , 765 , 766 , 767 , 769 , 770 , 771 , 772 , 773 , 774 , 1088 , 1105 , 1106 , 1111 , 1112 , 1135 ) , ovarian epithelial carcinoma ( 112 , 134 , 138 , 161 , 1105 , 1135 ) , pancreatic cancer ( 801 , 1424 , 1425 , 1426 ) , pancreatic carcinoma ( 801 , 1424 , 1425 , 1426 ) , pancreatic cancer, surrounding tissue ( 688 ) , multiple myeloma ( 470 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1193 , 1194 , 1195 , 1225 , 1226 , 1227 , 1323 , 1324 , 1325 , 1326 ) , prostate cancer ( 1423 , 1430 ) , salivary gland cancer ( 525 , 526 , 527 , 528 , 529 ) , melanoma skin cancer ( 258 , 259 , 260 , 261 , 262 , 263 , 518 , 519 , 520 , 521 , 522 , 523 , 532 , 533 , 534 , 536 , 593 , 610 , 621 , 622 ) , leiomyosarcoma ( 18 ) , rhabdomyosarcoma ( 18 ) , teratoma ( 227 ) , thymic carcinoma ( 100 , 101 , 102 , 103 ) , thyroid cancer ( 616 , 717 , 718 , 719 , 804 , 1022 , 1047 , 1333 ) , follicular thyroid carcinoma ( 1022 , 1047 , 1333 ) , thyroid cancer, surrounding tissue ( 617 ) , ventricular tachycardia ( 104 , 113 , 114 , 115 ) , hypersplenism ( 711 )
Relevant cell line - cell type - tissue:
'fat, white' ( 18 ) , 'liver, para-cholangiocellular carcinoma tissue' ( 125 ) , 143.98.2 (bone cell) ( 795 ) , 143B (bone cell) ( 756 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 246 ) , 293 (epithelial) [EphB2 (human), transfection] ( 246 ) , 293 (epithelial) [FGFR1 (human), transfection, ZNF198-FGFR1 fusion protein] ( 351 ) , 293T (epithelial) ( 1199 , 1354 , 1389 , 1396 , 1401 , 1402 , 1408 , 1409 ) , 42-MG-BA (glial) ( 1034 ) , 44-ZW-5409 (eye cell) ( 827 ) , 5637 (bladder cell) ( 988 ) , 639L (renal) ( 934 ) , 8-MG-BA (glial) ( 1233 ) , A172 (glial) ( 1190 , 1363 ) , A204 (muscle cell) ( 18 ) , A498 (renal) ( 1015 ) , A549 (pulmonary) ( 6 , 16 , 33 , 832 , 833 , 834 , 1431 ) , A673 (muscle cell) ( 18 ) , ACC-S (adenoidal) ( 544 , 546 ) , ACN ( 2 , 965 ) , ARH-77 (B lymphocyte) ( 1196 ) , AZ-521 (gastric) ( 715 ) , B lymphoid-blood ( 1242 , 1298 , 1432 , 1433 ) , bladder ( 307 , 308 ) , bone marrow ( 127 , 809 , 810 , 811 , 812 , 813 , 858 , 859 , 860 , 861 , 862 ) , brain ( 1081 , 1082 ) , breast ( 1 , 111 , 143 , 146 , 147 , 178 , 181 , 302 , 305 , 306 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 667 , 668 , 669 , 670 , 671 , 677 , 678 , 689 , 690 , 732 , 737 , 738 , 800 , 803 , 974 , 975 , 989 , 990 , 991 , 992 , 993 , 1006 ) , BT-549 (breast cell) ( 110 ) , Caki-2 (renal) ( 987 , 1014 , 1016 ) , Cal-12T (pulmonary) ( 12 ) , CAL-51 (breast cell) ( 958 , 959 ) , Calu-3 (pulmonary) ( 8 ) , CAMA-1 (breast cell) ( 110 ) , cardiac-heart ( 115 ) , CAS-1 (glial) ( 951 ) , cholangiocyte-liver ( 335 , 342 , 477 , 481 , 487 , 498 , 500 ) , CHP126 (neural crest) ( 2 , 980 ) , CHP212 (neural crest) ( 2 , 1220 ) , CHRF (megakaryocyte) ( 1025 , 1331 ) , CI-1 (B lymphocyte) ( 1217 ) , CMK (megakaryoblast) ( 1160 , 1374 ) , COLO-699 (pulmonary) ( 1058 ) , colon ( 128 , 129 , 130 , 131 , 132 , 133 , 149 , 171 , 186 , 187 , 188 , 190 , 474 , 475 , 499 , 501 , 502 , 503 , 504 , 644 , 645 , 646 , 647 , 648 , 649 ) , CTV-1 (myeloid) ( 1302 , 1316 , 1422 ) , DBTRG-05MG (glial) ( 1296 ) , DK-MG (glial) ( 1208 ) , DLD1 (intestinal) ( 18 ) , DMS153 (pulmonary) ( 11 ) , DND-41 (T lymphocyte) ( 1254 , 1255 ) , DU 145 (prostate cell) ( 1430 ) , DU.528 ('stem, hematopoietic') ( 1023 , 1364 ) , EHEB (B lymphocyte) ( 1403 ) , ELF-153 (megakaryocyte) ( 1371 ) , EOL-1 (myeloid) ( 985 , 986 ) , esophagus ( 373 , 374 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 453 , 456 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 467 , 468 ) , FU-OV-1 (ovarian) ( 1088 ) , G-292 (bone cell) ( 791 ) , GI-CA-N (neural crest) ( 2 , 952 ) , GI-LI-N (neuron) ( 2 , 966 ) , GI-ME-N (neuron) ( 2 , 961 ) , GRANTA-519 (B lymphocyte) ( 99 , 712 ) , HCC1143 (breast cell) ( 110 , 1290 ) , HCC1395 (breast cell) ( 110 , 1267 ) , HCC15 (pulmonary) ( 9 , 1113 ) , HCC1569 (breast cell) ( 110 ) , HCC44 (pulmonary) ( 12 , 1349 ) , HCC70 (breast cell) ( 110 , 960 ) , HCC78 (pulmonary) ( 10 , 80 , 83 , 84 ) , HCC827 (pulmonary) ( 8 , 835 , 836 ) , HD-MyZ (myeloid) ( 970 , 1085 ) , HDLM-2 (lymphoid) ( 971 , 1084 ) , HDQ-P1 (breast cell) ( 110 , 1045 ) , heart ( 104 , 113 , 114 , 642 , 672 , 673 , 674 , 675 , 684 , 685 , 686 , 687 , 700 , 701 , 702 ) , HEL (erythroid) ( 1026 , 1027 , 1143 , 1144 , 1301 , 1317 ) , HeLa (cervical) ( 3 , 15 , 595 , 606 , 607 , 608 ) , Hep3B (hepatic) ( 539 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 340 , 352 , 486 , 627 , 633 , 726 , 729 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 333 , 345 , 346 , 348 , 349 , 355 , 359 , 361 , 484 , 495 , 496 , 624 , 629 , 632 , 727 , 728 ) , hepatocyte-liver ( 332 , 334 , 341 , 343 , 347 , 350 , 353 , 354 , 357 , 360 , 478 , 488 , 497 , 626 , 628 , 631 , 676 ) , HES-3 ('stem, embryonic') ( 126 ) , HLE (hepatic) ( 490 ) , HLF (hepatic) ( 363 ) , HOS (bone cell) ( 755 ) , Hs683 (glial) ( 1191 ) , HU-3 (myeloid) ( 1372 ) , HUES-7 ('stem, embryonic') ( 344 ) , Huh28 (hepatic) ( 538 ) , HUVEC (endothelial) ( 548 , 549 , 550 , 551 , 552 , 1379 ) , JB-6 (lymphocyte) ( 1416 ) , JEKO-1 (B lymphocyte) ( 99 , 713 ) , JHH-2 (hepatic) ( 540 ) , Jurkat (T lymphocyte) ( 19 , 22 , 23 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 79 , 87 , 88 , 89 , 96 , 97 , 98 , 105 , 106 , 107 , 108 , 140 , 141 , 142 , 148 , 157 , 158 , 159 , 160 , 162 , 165 , 166 , 167 , 168 , 169 , 170 , 173 , 174 , 175 , 176 , 191 , 192 , 193 , 200 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 212 , 234 , 243 , 253 , 279 , 280 , 288 , 290 , 291 , 298 , 299 , 301 , 313 , 314 , 315 , 316 , 317 , 319 , 320 , 321 , 325 , 326 , 327 , 331 , 336 , 337 , 338 , 339 , 362 , 364 , 370 , 371 , 471 , 476 , 494 , 514 , 515 , 530 , 531 , 535 , 541 , 553 , 572 , 573 , 599 , 600 , 601 , 602 , 603 , 604 , 609 , 611 , 612 , 613 , 614 , 615 , 620 , 623 , 625 , 630 , 643 , 725 , 733 , 734 , 735 , 736 , 746 , 747 , 748 , 752 , 753 , 757 , 758 , 798 , 822 , 823 , 824 , 825 , 837 , 838 , 845 , 903 , 918 , 919 , 1044 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1293 , 1313 , 1314 , 1322 , 1329 , 1330 , 1376 , 1377 , 1393 , 1397 , 1398 , 1410 , 1418 , 1419 , 1420 , 1434 , 1435 , 1436 , 1437 , 1442 , 1443 , 1444 , 1445 , 1446 , 1447 , 1449 , 1450 , 1451 , 1452 ) , K4 (synoviocyte) ( 4 ) , K562 (erythroid) ( 15 , 34 , 35 , 36 , 37 , 38 , 78 , 86 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 163 , 164 , 172 , 215 , 220 , 222 , 224 , 225 , 232 , 233 , 244 , 245 , 247 , 248 , 249 , 250 , 251 , 252 , 255 , 256 , 257 , 264 , 265 , 266 , 276 , 277 , 278 , 281 , 282 , 289 , 300 , 303 , 304 , 318 , 365 , 366 , 367 , 368 , 379 , 380 , 381 , 509 , 510 , 511 , 516 , 517 , 634 , 652 , 663 , 664 , 665 , 666 , 706 , 730 , 731 , 739 , 740 , 759 , 760 , 789 , 790 , 796 , 797 , 799 , 839 , 840 , 841 , 842 , 843 , 844 , 854 , 855 , 856 , 857 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 954 , 955 , 956 , 957 , 968 , 973 , 1012 , 1013 , 1039 , 1040 , 1041 , 1042 , 1061 , 1062 , 1063 , 1064 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1128 , 1130 , 1131 , 1132 , 1133 , 1134 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1167 , 1169 , 1170 , 1171 , 1172 , 1173 , 1174 , 1175 , 1176 , 1271 , 1272 , 1273 , 1274 , 1275 , 1276 , 1277 , 1278 , 1279 , 1280 , 1281 , 1282 , 1300 , 1321 , 1394 , 1395 , 1438 , 1439 , 1440 , 1441 , 1448 ) , Karpas-1106P (B lymphocyte) ( 1219 ) , Karpas-299 (T lymphocyte) ( 1391 ) , KBM-3 (myeloid) ( 1421 ) , KG-1 (myeloid) ( 924 , 1258 , 1259 ) , kidney ( 310 , 312 , 323 , 328 , 761 , 762 ) , KM-H2 (lymphoid) ( 787 ) , KMS-11 (B lymphocyte) ( 254 , 1053 , 1054 , 1325 ) , KMS-18 (B lymphocyte) ( 1324 ) , KOPT-K1 (T lymphocyte) ( 1256 , 1257 ) , KY821 (myeloid) ( 127 , 1184 , 1332 ) , L1236 (lymphoid) ( 786 ) , L428 (lymphoid) ( 969 , 1086 ) , L540 (lymphoid) ( 202 , 972 , 1087 ) , LAN-5 (neural crest) ( 2 , 953 ) , larynx ( 653 , 807 , 814 ) , LCLC-103H (pulmonary) ( 1056 ) , liver ( 125 , 194 , 195 , 197 , 198 , 309 , 311 , 322 , 356 , 358 , 479 , 480 , 482 , 483 , 485 , 489 , 619 ) , LN18 (glial) ( 1269 ) , LN229 (glial) ( 1270 ) , LN405 (glial) ( 1035 ) , LN444 (glial) ( 283 , 284 , 285 , 286 , 287 ) , LOU-NH91 (squamous) ( 9 , 1262 ) , lung ( 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 90 , 91 , 92 , 93 , 94 , 95 , 109 , 144 , 145 , 150 , 182 , 183 , 185 , 189 , 216 , 217 , 218 , 219 , 221 , 223 , 228 , 229 , 230 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 324 , 369 , 372 , 375 , 376 , 377 , 378 , 505 , 506 , 507 , 508 , 512 , 513 , 542 , 543 , 574 , 575 , 581 , 582 , 591 , 592 , 596 , 691 , 692 , 693 , 694 , 695 , 704 , 705 , 707 , 708 , 741 , 742 , 743 , 744 , 745 , 802 , 805 , 806 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 913 , 914 , 915 , 916 , 917 , 920 , 921 , 922 , 927 , 928 , 929 , 930 , 994 , 1003 , 1004 , 1005 , 1007 , 1017 , 1018 , 1019 , 1020 , 1021 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1065 , 1066 , 1094 , 1095 , 1096 , 1097 , 1098 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1168 , 1188 , 1189 , 1205 , 1206 , 1207 , 1209 , 1210 , 1211 , 1213 , 1214 , 1215 , 1216 , 1221 , 1222 , 1223 , 1234 , 1235 , 1236 , 1237 , 1238 , 1243 , 1244 , 1245 , 1246 , 1247 , 1248 , 1249 , 1250 , 1251 , 1252 , 1253 , 1283 , 1284 , 1285 , 1286 , 1287 , 1288 , 1289 , 1294 , 1295 , 1304 , 1308 , 1309 , 1310 , 1311 , 1312 , 1337 , 1338 , 1339 , 1340 , 1341 , 1346 , 1347 , 1350 , 1351 , 1352 , 1355 , 1368 , 1369 , 1370 , 1382 , 1383 , 1384 , 1385 ) , LXF-289 (pulmonary) ( 1057 ) , lymphoid-blood ( 1359 , 1360 , 1361 ) , M059J (glial) ( 1268 ) , M059K (glial) ( 1319 ) , Mac1 (T lymphocyte) ( 1353 ) , MAVER-1 (B lymphocyte) ( 99 , 714 ) , MC-116 (B lymphocyte) ( 1218 ) , MCF-10A (breast cell) ( 139 , 1356 , 1357 , 1414 , 1415 ) , MCF-10A (breast cell) [CSFR (human), transfection] ( 139 ) , MDA-MB-157 (breast cell) ( 110 ) , MDA-MB-435S (breast cell) ( 110 , 1362 ) , MDA-MB-436 (breast cell) ( 110 , 828 ) , MDAH2774 (ovarian) ( 1111 ) , ME-F2 (myeloid) ( 127 , 1183 , 1334 ) , MG63 (bone cell) ( 754 ) , MHH-CALL4 (B lymphocyte) ( 1092 , 1104 ) , MIA PaCa-2 (pancreatic) ( 1424 , 1425 ) , MKN-1 (gastric) ( 716 ) , MKPL-1 (megakaryoblast) ( 821 , 1110 , 1375 ) , ML-1 (myeloid) ( 127 , 1022 , 1047 , 1333 ) , MNNG-HOS (bone cell) ( 1399 ) , MO-91 (myeloid) ( 1228 , 1229 ) , Molm 14 (myeloid) ( 127 , 382 , 977 , 1179 , 1327 ) , MOLT-15 (myeloid) ( 1366 ) , Mono Mac 6 (myeloid) ( 1177 , 1345 ) , muscle ( 18 ) , MV4-11 (macrophage) ( 127 , 466 , 469 , 849 , 850 , 851 , 852 , 853 , 978 , 979 , 1180 , 1328 , 1405 , 1406 ) , myeloid-bone marrow ( 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1089 , 1090 , 1091 , 1099 , 1100 , 1101 , 1102 , 1103 , 1107 , 1108 , 1109 , 1157 , 1158 , 1159 , 1185 , 1186 , 1187 , 1201 , 1202 , 1203 , 1204 , 1230 , 1231 , 1232 , 1343 ) , NALM19 (B lymphocyte) ( 1083 ) , NCCIT (epithelial) ( 227 ) , NCI-H1299 (pulmonary) ( 7 , 201 , 605 , 1318 ) , NCI-H1355 (pulmonary) ( 6 ) , NCI-H1373 (pulmonary) ( 1427 ) , NCI-H1437 (pulmonary) ( 11 , 12 ) , NCI-H1650 (pulmonary) ( 8 ) , NCI-H1666 (pulmonary) ( 12 ) , NCI-H1703 (squamous) ( 9 , 17 , 24 , 384 , 385 , 386 , 829 , 830 , 831 , 1378 , 1428 ) , NCI-H1734 (pulmonary) ( 7 ) , NCI-H1781 (pulmonary) ( 10 ) , NCI-H1792 (pulmonary) ( 6 , 492 , 493 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 491 ) , NCI-H1793 (pulmonary) ( 1320 ) , NCI-H1915 (pulmonary) ( 1261 ) , NCI-H1944 (pulmonary) ( 7 ) , NCI-H1975 (pulmonary) ( 8 , 201 , 1413 ) , NCI-H2030 (pulmonary) ( 1266 ) , NCI-H2052 (pulmonary) ( 1059 ) , NCI-H2073 (pulmonary) ( 9 , 11 , 1060 ) , NCI-H209 (pulmonary) ( 11 ) , NCI-H2106 (pulmonary) ( 8 ) , NCI-H2135 (pulmonary) ( 1200 ) , NCI-H2228 (pulmonary) ( 10 , 14 , 597 , 598 , 1367 ) , NCI-H2286 (pulmonary) ( 1265 ) , NCI-H23 (pulmonary) ( 6 ) , NCI-H2342 (pulmonary) ( 9 ) , NCI-H2405 (pulmonary) ( 12 ) , NCI-H2452 (pulmonary) ( 1055 ) , NCI-H28 (pulmonary) ( 1046 ) , NCI-H3122 (pulmonary) ( 10 ) , NCI-H358 (pulmonary) ( 7 ) , NCI-H441 (pulmonary) ( 6 ) , NCI-H460 (pulmonary) ( 7 , 1429 ) , NCI-H520 (squamous) ( 1335 ) , NCI-H596 (pulmonary) ( 1129 ) , NCI-H661 (pulmonary) ( 10 , 1342 ) , NCI-H716 (intestinal) ( 1093 ) , NCI-H838 (pulmonary) ( 11 , 1348 ) , NCI-H929 (B lymphocyte) ( 470 , 1195 ) , nerve ( 18 ) , NKM-1 (myeloid) ( 1181 , 1344 ) , NOMO-1 (myeloid) ( 127 , 846 , 1048 ) , NT2 (testicular) ( 226 ) , OCI-ly12 (B lymphocyte) ( 1411 ) , OCI-ly18 (B lymphocyte) ( 1412 ) , OCI-M1 (myeloid) ( 1315 ) , OCI/AML2 (myeloid) ( 1305 ) , OCI/AML3 (myeloid) ( 127 , 1141 , 1142 , 1306 ) , OPM-1 (B lymphocyte) ( 1051 , 1052 , 1326 ) , ovary ( 151 , 152 , 153 , 154 , 155 , 161 , 211 , 213 , 214 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 763 , 764 , 765 , 766 , 767 , 769 , 770 , 771 , 772 , 773 , 774 ) , OVKATE (ovarian) ( 135 ) , OVMANA (ovarian) ( 112 , 134 , 138 ) , OVSAHO (ovarian) ( 136 , 156 ) , PA-1 (ovarian) ( 1106 , 1112 ) , PANC-1 (pancreatic) ( 1426 ) , pancreas ( 688 , 801 ) , PC3 (prostate cell) ( 1423 ) , PL21 (myeloid) ( 1178 , 1307 ) , RD18 (muscle cell) ( 18 ) , Reh (B lymphocyte) ( 1137 , 1138 ) , RPMI-8226 (plasma cell) ( 1049 , 1050 , 1323 ) , RS4;11 (B lymphocyte) ( 127 , 1139 , 1140 ) , SACC-83 (salivary gland) ( 545 , 547 ) , salivary gland ( 525 , 526 , 527 , 528 , 529 ) , Saos-2 (bone cell) ( 18 ) , SD1 (lymphoblastoid) ( 1136 , 1386 , 1387 ) , SEM (B lymphocyte) ( 127 , 383 , 1008 , 1009 , 1010 , 1011 , 1182 , 1390 , 1407 , 1417 ) , SiMa (neural crest) ( 2 , 981 ) , SJSA-1 (bone cell) ( 792 ) , SK-ES-1 ( 793 ) , SK-HEP-1 (endothelial) ( 473 ) , SK-LMS-1 (muscle cell) ( 18 ) , SK-N-MC (neural crest) ( 2 , 1263 ) , skin ( 177 , 179 , 180 , 184 , 258 , 259 , 260 , 261 , 262 , 263 , 518 , 519 , 520 , 521 , 522 , 523 , 532 , 533 , 534 , 536 , 593 , 610 , 621 , 622 ) , SKNAS (neural crest) ( 2 , 1260 ) , SKNDZ (neural crest) ( 2 , 1036 ) , SKNFI (neural crest) ( 2 , 1037 ) , SKNSH (neural crest) ( 2 , 1239 ) , SNB-19 (glial) ( 1240 ) , SNU-398 (hepatic) ( 524 ) , SNU-449 (hepatic) ( 472 ) , SNU-5 (gastric) ( 976 ) , spleen ( 711 ) , stomach ( 292 , 293 , 294 , 295 , 296 , 297 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 576 , 577 , 578 , 579 , 580 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 679 , 680 , 681 , 682 , 683 , 696 , 697 , 698 , 699 , 703 , 709 , 710 , 720 , 721 , 722 , 723 , 724 ) , SUP-M2 (T lymphocyte) ( 1400 ) , SUP-T13 (T lymphocyte) ( 1024 , 1365 ) , SW1710 (bladder cell) ( 936 ) , SW1783 (glial) ( 1264 ) , SW480 (intestinal) ( 749 , 750 , 1336 ) , T1-73 (bone cell) ( 794 ) , T98G (glial) ( 1303 ) , TERT20 ('stem, mesenchymal') ( 618 ) , thymus ( 100 , 101 , 102 , 103 ) , thyroid ( 616 , 617 , 717 , 718 , 719 , 804 ) , TOV112D (ovarian) ( 1105 , 1135 ) , TS (lymphocyte) ( 1197 , 1241 , 1291 , 1292 , 1299 , 1404 ) , TYK-nu (ovarian) ( 137 ) , U-118MG (glial) ( 81 , 82 , 85 , 537 , 594 , 1388 ) , U-138 MG (glial) ( 1038 ) , U266 (plasma cell) ( 1194 ) , U87MG (glial) ( 329 ) , U87MG (glial) [EGFR (human), transfection] ( 329 ) , UM-UC-1 (bladder cell) ( 1043 ) , UT-7 (myeloid) ( 1358 , 1373 ) , WSU-NHL (B lymphocyte) ( 1212 ) , XG1 (B lymphocyte) ( 1193 , 1225 ) , XG4 (B lymphocyte) ( 1226 ) , XG6 (B lymphocyte) ( 1227 ) , Z-55 (myeloid) ( 1224 )

Upstream Regulation
Regulatory protein:
CSFR (human) ( 139 ) , EGFR (human) ( 329 ) , FGFR1 (human) ( 351 )
Treatments:
ephrin_B1 ( 246 ) , ephrin_B2 ( 246 )

References 

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

3

Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info

4

Bordoli MR, et al. (2014) A secreted tyrosine kinase acts in the extracellular environment. Cell 158, 1033-44
25171405   Curated Info

5

Yoshida T, et al. (2014) Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20, 4059-74
24919575   Curated Info

6

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

7

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

8

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

12

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

13

Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96
23911959   Curated Info

14

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

15

Zhou H, et al. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12, 260-71
23186163   Curated Info

16

Rikova K (2012) CST Curation Set: 16140; Year: 2012; Biosample/Treatment: cell line, A549/iressa, gleevec, crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

17

Rikova K (2012) CST Curation Set: 16139; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

18

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

19

Zhou J (2012) CST Curation Set: 14432; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

20

Rikova K (2012) CST Curation Set: 14270; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 1mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

21

Rikova K (2012) CST Curation Set: 14271; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 2mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

22

Zhou J (2012) CST Curation Set: 14185; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

23

Mulhern D (2012) CST Curation Set: 13112; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

24

Possemato A (2012) CST Curation Set: 13553; Year: 2012; Biosample/Treatment: cell line, NCI-H1703/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

25

Possemato A (2012) CST Curation Set: 13532; Year: 2012; Biosample/Treatment: cell line, Jurkat/untreated; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

26

Zhou J (2012) CST Curation Set: 12609; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

27

Zhou J (2012) CST Curation Set: 12611; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

28

Zhou J (2012) CST Curation Set: 12612; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

29

Mulhern D (2012) CST Curation Set: 13337; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

30

Mulhern D (2012) CST Curation Set: 13338; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

31

Mulhern D (2012) CST Curation Set: 13335; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

32

Mulhern D (2012) CST Curation Set: 13336; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

33

Rikova K (2012) CST Curation Set: 13324; Year: 2012; Biosample/Treatment: cell line, A549/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

34

Zhou J (2011) CST Curation Set: 12806; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

35

Zhou J (2011) CST Curation Set: 12808; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

36

Zhou J (2011) CST Curation Set: 12809; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

37

Mulhern D (2011) CST Curation Set: 13266; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

38

Mulhern D (2011) CST Curation Set: 13267; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

39

Mulhern D (2011) CST Curation Set: 13106; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

40

Mulhern D (2011) CST Curation Set: 13111; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

41

Mulhern D (2011) CST Curation Set: 12689; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

42

Mulhern D (2011) CST Curation Set: 12691; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

43

Mulhern D (2011) CST Curation Set: 12697; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

44

Mulhern D (2011) CST Curation Set: 13031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

45

Mulhern D (2011) CST Curation Set: 13033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

46

Mulhern D (2011) CST Curation Set: 12690; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

Mulhern D (2011) CST Curation Set: 12692; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

48

Mulhern D (2011) CST Curation Set: 12696; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

Mulhern D (2011) CST Curation Set: 12643; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

Mulhern D (2011) CST Curation Set: 12644; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

51

Mulhern D (2011) CST Curation Set: 12578; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Mulhern D (2011) CST Curation Set: 12579; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Mulhern D (2011) CST Curation Set: 12580; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

54

Mulhern D (2011) CST Curation Set: 12581; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

Mulhern D (2011) CST Curation Set: 12582; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

Mulhern D (2011) CST Curation Set: 12472; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

57

Mulhern D (2011) CST Curation Set: 12473; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

58

Mulhern D (2011) CST Curation Set: 12474; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

59

Mulhern D (2011) CST Curation Set: 12475; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Zhou J (2011) CST Curation Set: 12495; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Zhou J (2011) CST Curation Set: 12497; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

Zhou J (2011) CST Curation Set: 12344; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

63

Zhou J (2011) CST Curation Set: 12345; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

Zhou J (2011) CST Curation Set: 12347; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

65

Mulhern D (2011) CST Curation Set: 12399; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

66

Mulhern D (2011) CST Curation Set: 12401; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

67

Zhou J (2011) CST Curation Set: 12314; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

68

Zhou J (2011) CST Curation Set: 12317; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

69

Zhou J (2011) CST Curation Set: 12318; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

70

Zhou J (2011) CST Curation Set: 12319; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

71

Zhou J (2011) CST Curation Set: 12320; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Zhou J (2011) CST Curation Set: 12025; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Zhou J (2011) CST Curation Set: 12026; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

74

Zhou J (2011) CST Curation Set: 12030; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

75

Zhou J (2011) CST Curation Set: 12031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

76

Zhou J (2011) CST Curation Set: 12032; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

77

Zhou J (2011) CST Curation Set: 12033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

78

Bergström Lind S, et al. (2011) Toward a comprehensive characterization of the phosphotyrosine proteome. Cell Signal 23, 1387-95
21447384   Curated Info

79

Moritz A (2011) CST Curation Set: 12258; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Artemenko KA, et al. (2011) Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry. Analyst 136, 1971-8
21403953   Curated Info

87

Guo A (2011) CST Curation Set: 11646; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Guo A (2011) CST Curation Set: 11647; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Guo A (2011) CST Curation Set: 11648; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Ren H (2011) CST Curation Set: 11772; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

91

Ren H (2011) CST Curation Set: 11773; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

Ren H (2011) CST Curation Set: 11775; Year: 2011; Biosample/Treatment: cell line, RP92/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

Ren H (2011) CST Curation Set: 11779; Year: 2011; Biosample/Treatment: cell line, RP96/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Possemato A (2011) CST Curation Set: 11712; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Possemato A (2011) CST Curation Set: 11713; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Possemato A (2011) CST Curation Set: 11718; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

Pighi C, et al. (2011) Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell Oncol (Dordr) 34, 141-53
21394647   Curated Info

100

Li Y (2011) CST Curation Set: 10458; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Li Y (2011) CST Curation Set: 10461; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Li Y (2011) CST Curation Set: 10520; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Possemato A (2011) CST Curation Set: 11628; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Possemato A (2011) CST Curation Set: 11629; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Possemato A (2011) CST Curation Set: 11632; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Possemato A (2011) CST Curation Set: 11633; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Tucker M (2011) CST Curation Set: 10947; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Albeck JG, Brugge JS (2011) Uncovering a tumor suppressor for triple-negative breast cancers. Cell 144, 638-40
21376226   Curated Info

111

Tucker M (2011) CST Curation Set: 10925; Year: 2011; Biosample/Treatment: tissue, breast/untreated; Disease: breast cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Ren H (2011) CST Curation Set: 11303; Year: 2011; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Li Y (2011) CST Curation Set: 10456; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Li Y (2011) CST Curation Set: 10441; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Li Y (2011) CST Curation Set: 10452; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Moritz A (2011) CST Curation Set: 11304; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

Moritz A (2011) CST Curation Set: 11305; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

Moritz A (2011) CST Curation Set: 11306; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Moritz A (2011) CST Curation Set: 11307; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Moritz A (2011) CST Curation Set: 11308; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Moritz A (2011) CST Curation Set: 11309; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Moritz A (2011) CST Curation Set: 11310; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Moritz A (2011) CST Curation Set: 11311; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

Moritz A (2011) CST Curation Set: 11312; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Gu TL, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
21253578   Curated Info

126

Ding VM, et al. (2011) Tyrosine phosphorylation profiling in fgf-2 stimulated human embryonic stem cells. PLoS One 6, e17538
21437283   Curated Info

127

Gu TL, et al. (2011) Survey of activated FLT3 signaling in leukemia. PLoS One 6, e19169
21552520   Curated Info

128

Tucker M (2010) CST Curation Set: 10852; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991